Dave Schulte is a Managing Director at McKesson Ventures and an accomplished health care and technology investor.
Prior to McKesson Ventures, he helped build Kaiser Permanente’s Venture program from $20M to $400M of assets under management and managed the investment team.
His current and prior investments include: Landmark Health, SHYFT Analytics, Komodo Health, Aledade, Omada Health, Proteus Digital Health, Ingenious Med, MetricStream, Atheromed and Torax Medical.
Dave was also a software and health care investment banker at J.P. Morgan (Hambrecht & Quist), UBS, and Piper Jaffray. He is a graduate of St. John’s University and earned a Master of Public Policy degree from Harvard University.
Dave grew up in Minneapolis, where he was an all-state soccer and all-conference basketball player. Now he aspires to “all-backyard” in the eyes of his children.